These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2569298

  • 1. Differential effects of nebivolol, atenolol and propranolol on heart rate and on bronchoconstrictor responses to histamine in the guinea-pig.
    De Clerck F, Van Gorp L, Loots W, Janssen PA.
    Arch Int Pharmacodyn Ther; 1989; 298():230-6. PubMed ID: 2569298
    [Abstract] [Full Text] [Related]

  • 2. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR, Marchione CS.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [Abstract] [Full Text] [Related]

  • 3. Effects of cardioselective beta blockade on the peripheral lung in guinea pigs.
    Clerici C, Macquin-Mavier I, Harf A.
    Eur Respir J; 1988 Jan; 1(1):10-4. PubMed ID: 2896599
    [Abstract] [Full Text] [Related]

  • 4. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A, Feely J.
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [Abstract] [Full Text] [Related]

  • 5. Relationship between the sympatholytic action of nebivolol and hypotension.
    Ward JE, Coles P, Cox H, Eisenhofer G, Angus JA.
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
    [Abstract] [Full Text] [Related]

  • 6. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J, Cobo C, Geukens H, Verhaegen H.
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL, Routledge HC, Kendall MJ.
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [Abstract] [Full Text] [Related]

  • 9. Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
    Sal'nikov EV.
    Bull Exp Biol Med; 2009 Feb; 147(2):181-4. PubMed ID: 19513416
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol and airway responsiveness in the rabbit.
    D'Agostino B, Gallelli L, Falciani M, Fici F, Mangrella M, Rossi F, Filippelli A.
    Life Sci; 2001 Mar 23; 68(18):2159-68. PubMed ID: 11324721
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L.
    J Pharmacol Exp Ther; 1972 Jun 23; 181(3):434-45. PubMed ID: 4402373
    [No Abstract] [Full Text] [Related]

  • 12. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
    Kubli S, Feihl F, Waeber B.
    Clin Pharmacol Ther; 2001 Apr 23; 69(4):238-44. PubMed ID: 11309552
    [Abstract] [Full Text] [Related]

  • 13. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L, Wijns W, van Eyll C, Bouvy T, Van Nueten L, Pouleur H.
    J Cardiovasc Pharmacol; 1993 Aug 23; 22(2):183-90. PubMed ID: 7692155
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of nebivolol in man.
    Van Bortel LM, de Hoon JN, Kool MJ, Wijnen JA, Vertommen CI, Van Nueten LG.
    Eur J Clin Pharmacol; 1997 Aug 23; 51(5):379-84. PubMed ID: 9049578
    [Abstract] [Full Text] [Related]

  • 15. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I.
    Life Sci; 2007 Jul 12; 81(5):399-404. PubMed ID: 17628611
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of nebivolol on adrenoceptors in the heart and in resistance arterioles in the rat. Quantitative intravital microscopic analysis.
    Loots W, De Clerck F.
    Eur J Pharmacol; 1990 Apr 10; 179(1-2):177-86. PubMed ID: 1973102
    [Abstract] [Full Text] [Related]

  • 17. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
    Chlopicki S, Kozlovski VI, Gryglewski RJ.
    J Physiol Pharmacol; 2002 Dec 10; 53(4 Pt 1):615-24. PubMed ID: 12512696
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 10; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 19. Exercise tolerance with nebivolol and atenolol.
    Van Bortel LM, van Baak MA.
    Cardiovasc Drugs Ther; 1992 Jun 10; 6(3):239-47. PubMed ID: 1353367
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
    Van de Water A, Janssens W, Van Neuten J, Xhonneux R, De Cree J, Verhaegen H, Reneman RS, Janssen PA.
    J Cardiovasc Pharmacol; 1988 May 10; 11(5):552-63. PubMed ID: 2455841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.